Korsuva

30/12/2020 0

Cara Therapeutics Submits New Drug Application to U.S. Food and Drug Administration for Korsuva Injection in Hemodialysis Patients with Moderate-to-Severe Pruritus STAMFORD, Conn., Dec. 28, […]

Tlando

10/12/2020 0

Lipocine Announces Tentative Approval of TLANDO SALT LAKE CITY, Dec. 8, 2020 /PRNewswire/ — Lipocine Inc. (NASDAQ: LPCN), a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders, […]

arimoclomol

19/09/2020 0

arimoclomol Orphazyme Announces FDA Acceptance and Priority Review of New Drug Application for Arimoclomol for Niemann-Pick Disease Type C Copenhagen, Denmark, September 16, 2020 – Orphazyme […]